TABLE 1.
Risk factors for CMV disease | References |
---|---|
CMV seropositivity | Shepp et al (3) |
CD4 cell count nadir <100 cells/µL | Gallant et al (2) |
Prior occurrence of other opportunistic infections | Burke et al (54) |
CMV viremia in polymorphonuclear leukocytes or plasma | Dodt et al (28), Casado et al (55), Spector et al (29), Walmsley et al (30) |
HIV plasma viremia | Spector et al (29) |
Prior retinal damage (cotton wool spots) | Jacobson and Mills (56) |
Previous CMV disease (retinal or extraocular) | Verbraak et al (31) |
Lack of anti-CMV therapy | Spector et al (57) |
Lack of highly active antiretroviral therapy (HAART) | Verbraak et al (14) |